{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:52:19Z","timestamp":1794869539232,"version":"4.9.1"},"reference-count":92,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Epigenetic modulations are currently emerging as promising targets in metabolic diseases,\nincluding non-alcoholic fatty liver disease (NAFLD), for their roles in pathogenesis and therapeutic\npotential. The molecular mechanisms and modulation potential of histone methylation as a histone\npost-transcriptional modification in NAFLD have been recently addressed. However, a detailed overview\nof the histone methylation regulation in NAFLD is lacking. In this review, we comprehensively\nsummarize the mechanisms of histone methylation regulation in NAFLD. We conducted a comprehensive\ndatabase search in the PubMed database with the keywords 'histone', 'histone methylation',\n'NAFLD', and 'metabolism' without time restriction. Reference lists of key documents were also reviewed\nto include potentially omitted articles. It has been reported that these enzymes can interact\nwith other transcription factors or receptors under pro-NAFLD conditions, such as nutritional stress,\nwhich lead to recruitment to the promoters or transcriptional regions of key genes involved in glycolipid\nmetabolism, ultimately regulating gene transcriptional activity to influence the expression. Histone\nmethylation regulation has been implicated in mediating metabolic crosstalk between tissues or\norgans in NAFLD and serves a critical role in NAFLD development and progression. Some dietary\ninterventions or agents targeting histone methylation have been suggested to improve NAFLD; however,\nthere is still a lack of additional research and clinical translational relevance. In conclusion, histone\nmethylation\/demethylation has demonstrated an important regulatory role in NAFLD by mediating\nthe expression of key glycolipid metabolism-related genes, and more research is needed in the future\nto explore its potential as a therapeutic target.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389203724666230526155643","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T04:36:36Z","timestamp":1685334996000},"page":"465-476","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Histone Methylation Regulation as a Potential Target for Non-alcoholic\nFatty Liver Disease"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-0288","authenticated-orcid":true,"given":"Yuanbin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, No. 99 Zhang Zhidong Road, Wuhan, Hubei,\n430000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-0523","authenticated-orcid":true,"given":"Mingkai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Renmin Hospital of Wuhan University, No. 99 Zhang Zhidong Road, Wuhan, Hubei,\n430000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"Riazi K.","year":"2022","unstructured":"Riazi K.; Azhari H.; Charette J.H.; Underwood F.E.; King J.A.; Afshar E.E.; Swain M.G.; Congly S.E.; Kaplan G.G.; Shaheen A.A.; The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022,7(9),851-861","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"Powell E.E.","year":"2021","unstructured":"Powell E.E.; Wong V.W.S.; Rinella M.; Non-alcoholic fatty liver disease. Lancet 2021,397(10290),2212-2224","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"m4747","DOI":"10.1136\/bmj.m4747","volume":"372","author":"Petroni M.L.","year":"2021","unstructured":"Petroni M.L.; Brodosi L.; Bugianesi E.; Marchesini G.; Management of non-alcoholic fatty liver disease. BMJ 2021,372,m4747","journal-title":"BMJ"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","volume":"72","author":"Tr\u00e9po E.","year":"2020","unstructured":"Tr\u00e9po E.; Valenti L.; Update on NAFLD genetics: From new variants to the clinic. J Hepatol 2020,72(6),1196-1209","journal-title":"J Hepatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"Ling C.","year":"2019","unstructured":"Ling C.; R\u00f6nn T.; Epigenetics in human obesity and type 2 diabetes. Cell Metab 2019,29(5),1028-1044","journal-title":"Cell Metab"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Lu Q.; Chang C.; Epigenetics in health and disease. Adv Exp Med Biol 2020,1253,3-55","journal-title":"Adv Exp Med Biol"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105484","volume":"167","author":"Sodum N.","year":"2021","unstructured":"Sodum N.; Kumar G.; Bojja S.L.; Kumar N.; Rao C.M.; Epigenetics in NAFLD\/NASH: Targets and therapy. Pharmacol Res 2021,167","journal-title":"Pharmacol Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s12276-022-00812-1","volume":"54","author":"Kim J.","year":"2022","unstructured":"Kim J.; Lee H.; Yi S.J.; Kim K.; Gene regulation by histone-modifying enzymes under hypoxic conditions: A focus on histone methylation and acetylation. Exp Mol Med 2022,54(7),878-889","journal-title":"Exp Mol Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/EBC20180067","volume":"63","author":"Tolsma T.O.","year":"2019","unstructured":"Tolsma T.O.; Hansen J.C.; Post-translational modifications and chromatin dynamics. Essays Biochem 2019,63(1),89-96","journal-title":"Essays Biochem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-15-8104-5_1","volume":"1283","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Sun Z.; Jia J.; Du T.; Zhang N.; Tang Y.; Fang Y.; Fang D.; Overview of histone modification. Adv Exp Med Biol 2021,1283,1-16","journal-title":"Adv Exp Med Biol"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.784591","volume":"12","author":"Cai Q.","year":"2021","unstructured":"Cai Q.; Gan C.; Tang C.; Wu H.; Gao J.; Mechanism and therapeutic opportunities of histone modifications in chronic liver disease. Front Pharmacol 2021,12","journal-title":"Front Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.3390\/ijms21228617","volume":"21","author":"Lim H.J.","year":"2020","unstructured":"Lim H.J.; Kim M.; EZH2 as a potential target for NAFLD therapy. Int J Mol Sci 2020,21(22),8617","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","volume":"20","author":"Michalak E.M.","year":"2019","unstructured":"Michalak E.M.; Burr M.L.; Bannister A.J.; Dawson M.A.; The roles of DNA, RNA and histone methylation in ageing and cancer. Nat Rev Mol Cell Biol 2019,20(10),573-589","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrm.2017.94","volume":"19","author":"Fyodorov D.V.","year":"2018","unstructured":"Fyodorov D.V.; Zhou B.R.; Skoultchi A.I.; Bai Y.; Emerging roles of linker histones in regulating chromatin structure and function. Nat Rev Mol Cell Biol 2018,19(3),192-206","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/EBC20180056","volume":"63","author":"Zhou B.R.","year":"2019","unstructured":"Zhou B.R.; Bai Y.; Chromatin structures condensed by linker histones. Essays Biochem 2019,63(1),75-87","journal-title":"Essays Biochem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biom7010003","volume":"7","author":"Castillo-Aguilera O.","year":"2017","unstructured":"Castillo-Aguilera O.; Depreux P.; Halby L.; Arimondo P.; Goossens L.; DNA methylation targeting: The DNMT\/HMT crosstalk challenge. Biomolecules 2017,7(4),3","journal-title":"Biomolecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mrrev.2017.09.003","volume":"780","author":"Gong F.","year":"2019","unstructured":"Gong F.; Miller K.M.; Histone methylation and the DNA damage response. Mutat Res Rev Mutat Res 2019,780,37-47","journal-title":"Mutat Res Rev Mutat Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s00018-015-2001-4","volume":"72","author":"Zhang X.","year":"2015","unstructured":"Zhang X.; Huang Y.; Shi X.; Emerging roles of lysine methylation on non-histone proteins. Cell Mol Life Sci 2015,72(22),4257-4272","journal-title":"Cell Mol Life Sci"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016742118","volume":"118","author":"Zhao S.","year":"2021","unstructured":"Zhao S.; Chuh K.N.; Zhang B.; Dul B.E.; Thompson R.E.; Farrelly L.A.; Liu X.; Xu N.; Xue Y.; Roeder R.G.; Maze I.; Muir T.W.; Li H.; Histone H3Q5 serotonylation stabilizes H3K4 methylation and potentiates its readout. Proc Natl Acad Sci 2021,118(6)","journal-title":"Proc Natl Acad Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"Black J.C.","year":"2012","unstructured":"Black J.C.; Van Rechem C.; Whetstine J.R.; Histone lysine methylation dynamics: Establishment, regulation, and biological impact. Mol Cell 2012,48(4),491-507","journal-title":"Mol Cell"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"Buzzetti E.","year":"2016","unstructured":"Buzzetti E.; Pinzani M.; Tsochatzis E.A.; The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016,65(8),1038-1048","journal-title":"Metabolism"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"Bessone F.","year":"2019","unstructured":"Bessone F.; Razori M.V.; Roma M.G.; Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci 2019,76(1),99-128","journal-title":"Cell Mol Life Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"Loomba R.","year":"2021","unstructured":"Loomba R.; Friedman S.L.; Shulman G.I.; Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021,184(10),2537-2564","journal-title":"Cell"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"Anstee Q.M.","year":"2019","unstructured":"Anstee Q.M.; Reeves H.L.; Kotsiliti E.; Govaere O.; Heikenwalder M.; From NASH to HCC: Current concepts and future challenges. Nat Rev Gastroenterol Hepatol 2019,16(7),411-428","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061870","volume":"8","author":"Goldsworthy M.","year":"2013","unstructured":"Goldsworthy M.; Absalom N.L.; Schr\u00f6ter D.; Matthews H.C.; Bogani D.; Moir L.; Long A.; Church C.; Hugill A.; Anstee Q.M.; Goldin R.; Thursz M.; Hollfelder F.; Cox R.D.; Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice. PLoS One 2013,8(6)","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.celrep.2016.10.023","volume":"17","author":"Kim D.H.","year":"2016","unstructured":"Kim D.H.; Kim J.; Kwon J.S.; Sandhu J.; Tontonoz P.; Lee S.K.; Lee S.; Lee J.W.; Critical roles of the histone methyltransferase MLL4\/KMT2D in murine hepatic steatosis directed by ABL1 and PPAR\u03b32. Cell Rep 2016,17(6),1671-1682","journal-title":"Cell Rep"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118007","volume":"256","author":"Han Y.H.","year":"2020","unstructured":"Han Y.H.; Kim H.J.; Choi H.; Lee S.; Lee M.O.; ROR\u03b1 autoregulates its transcription via MLL4-associated enhancer remodeling in the liver. Life Sci 2020,256","journal-title":"Life Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/hep.30284","volume":"69","author":"Kim J.","year":"2019","unstructured":"Kim J.; Lee B.; Kim D.H.; Yeon J.G.; Lee J.; Park Y.; Lee Y.; Lee S.K.; Lee S.; Lee J.W.; UBE3A suppresses overnutrition\u2010induced expression of the steatosis target genes of MLL4 by degrading MLL4. Hepatology 2019,69(3),1122-1134","journal-title":"Hepatology"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.244749","volume":"134","author":"Talbert P.B.","year":"2021","unstructured":"Talbert P.B.; Henikoff S.; Histone variants at a glance. J Cell Sci 2021,134(6)","journal-title":"J Cell Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1096\/fj.14-262717","volume":"29","author":"Podrini C.","year":"2015","unstructured":"Podrini C.; Koffas A.; Chokshi S.; Vinciguerra M.; Lelliott C.J.; White J.K.; Adissu H.A.; Williams R.; Greco A.; MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat\u2010induced steatosis. FASEB J 2015,29(5),1676-1687","journal-title":"FASEB J"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.153994","volume":"101","author":"Tucker B.","year":"2019","unstructured":"Tucker B.; Li H.; Long X.; Rye K.A.; Ong K.L.; Fibroblast growth factor 21 in non-alcoholic fatty liver disease. Metabolism 2019,101","journal-title":"Metabolism"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1074\/jbc.M112.433482","volume":"288","author":"Tong X.","year":"2013","unstructured":"Tong X.; Zhang D.; Buelow K.; Guha A.; Arthurs B.; Brady H.J.M.; Yin L.; Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein. J Biol Chem 2013,288(8),5417-5425","journal-title":"J Biol Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.2337\/db20-0437","volume":"69","author":"Zhang W.","year":"2020","unstructured":"Zhang W.; Yang D.; Yuan Y.; Liu C.; Chen H.; Zhang Y.; Wang Q.; Petersen R.B.; Huang K.; Zheng L.; Muscular G9a regulates muscle-liver-fat axis by musclin under overnutrition in female mice. Diabetes 2020,69(12),2642-2654","journal-title":"Diabetes"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1124\/dmd.120.000195","volume":"48","author":"Pande P.","year":"2020","unstructured":"Pande P.; Zhong X.; Ku W.W.; Histone methyltransferase g9a regulates expression of nuclear receptors and cytochrome P450 enzymes in heparg cells at basal level and in fatty acid induced steatosis. Drug Metab Dispos 2020,48(12),1321-1329","journal-title":"Drug Metab Dispos"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115663","volume":"9","author":"Ohno M.","year":"2014","unstructured":"Ohno M.; Kanayama T.; Moore R.; Ray M.; Negishi M.; The roles of co-chaperone CCRP\/DNAJC7 in Cyp2b10 gene activation and steatosis development in mouse livers. PLoS One 2014,9(12)","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11745-011-3635-0","volume":"47","author":"Yu H.","year":"2012","unstructured":"Yu H.; Wu J.; Yang M.; Guo J.; Zheng L.; Peng M.; Zhang Q.; Xiang Y.; Cao J.; Shen W.; Involvement of liver X receptor alpha in histone modifications across the target fatty acid synthase gene. Lipids 2012,47(3),249-257","journal-title":"Lipids"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.3390\/ijms21113858","volume":"21","author":"de Gregorio E.","year":"2020","unstructured":"de Gregorio E.; Colell A.; Morales A.; Mar\u00ed M.; Relevance of SIRT1-NF-\u03baB axis as therapeutic target to ameliorate inflammation in liver disease. Int J Mol Sci 2020,21(11),3858","journal-title":"Int J Mol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/jcp.29026","volume":"235","author":"Dziewulska A.","year":"2020","unstructured":"Dziewulska A.; Dobosz A.M.; Dobrzyn A.; Smolinska A.; Kolczynska K.; Ntambi J.M.; Dobrzyn P.; SCD1 regulates the AMPK\/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle. J Cell Physiol 2020,235(2),1129-1140","journal-title":"J Cell Physiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bbrc.2017.02.093","volume":"485","author":"Shao J.","year":"2017","unstructured":"Shao J.; Li L.; Xu H.; Yang L.; Bian Y.; Fang M.; Xu Y.; Suv39h2 deficiency ameliorates diet-induced steatosis in mice. Biochem Biophys Res Commun 2017,485(3),658-664","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/hep.29127","volume":"65","author":"Fan Z.","year":"2017","unstructured":"Fan Z.; Li L.; Li M.; Zhang X.; Hao C.; Yu L.; Zeng S.; Xu H.; Fang M.; Shen A.; Jenuwein T.; Xu Y.; The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice. Hepatology 2017,65(6),1904-1919","journal-title":"Hepatology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"24154","DOI":"10.3390\/ijms141224154","volume":"14","author":"Vella S.","year":"2013","unstructured":"Vella S.; Gnani D.; Crudele A.; Ceccarelli S.; De Stefanis C.; Gaspari S.; Nobili V.; Locatelli F.; Marquez V.; Rota R.; Alisi A.; EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD. Int J Mol Sci 2013,14(12),24154-24168","journal-title":"Int J Mol Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biology9050093","volume":"9","author":"Lee S.","year":"2020","unstructured":"Lee S.; Woo D.C.; Kang J.; Ra M.; Kim K.H.; Lee S.R.; Choi D.K.; Lee H.; Hong K.B.; Min S.H.; Lee Y.; Yu J.H.; The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice. Biology 2020,9(5),93","journal-title":"Biology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.10.039","volume":"525","author":"Wu F.","year":"2022","unstructured":"Wu F.; Xu L.; Tu Y.; Cheung O.K.W.; Szeto L.L.M.; Mok M.T.S.; Yang W.; Kang W.; Cao Q.; Lai P.B.S.; Chan S.L.; Tan P.; Sung J.J.Y.; Yip K.Y.; Cheng A.S.L.; To K.F.; Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis. Cancer Lett 2022,525,115-130","journal-title":"Cancer Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2337\/db20-1110","volume":"70","author":"Shuai L.","year":"2021","unstructured":"Shuai L.; Li B.H.; Jiang H.W.; Yang L.; Li J.; Li J.Y.; DOT1L regulates thermogenic adipocyte differentiation and function via modulating H3K79 methylation. Diabetes 2021,70(6),1317-1333","journal-title":"Diabetes"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1101\/gad.177444.111","volume":"26","author":"Beck D.B.","year":"2012","unstructured":"Beck D.B.; Oda H.; Shen S.S.; Reinberg D.; PR-Set7 and H4K20me1: At the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. Genes Dev 2012,26(4),325-337","journal-title":"Genes Dev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.celrep.2017.07.003","volume":"20","author":"Nikolaou K.C.","year":"2017","unstructured":"Nikolaou K.C.; Moulos P.; Harokopos V.; Chalepakis G.; Talianidis I.; Kmt5a controls hepatic metabolic pathways by facilitating RNA Pol II release from promoter-proximal regions. Cell Rep 2017,20(4),909-922","journal-title":"Cell Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","volume":"72","author":"Stopa N.","year":"2015","unstructured":"Stopa N.; Krebs J.E.; Shechter D.; The PRMT5 arginine methyltransferase: Many roles in development, cancer and beyond. Cell Mol Life Sci 2015,72(11),2041-2059","journal-title":"Cell Mol Life Sci"},{"key":"ref=48","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120336","volume":"293","author":"Wang D.","year":"2022","unstructured":"Wang D.; Tan K.S.; Zeng W.; Li S.; Wang Y.; Xu F.; Tan W.; Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription. Life Sci 2022,293","journal-title":"Life Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"10884","DOI":"10.1074\/jbc.RA118.002377","volume":"293","author":"Huang L.","year":"2018","unstructured":"Huang L.; Liu J.; Zhang X.O.; Sibley K.; Najjar S.M.; Lee M.M.; Wu Q.; Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis. J Biol Chem 2018,293(28),10884-10894","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1016\/j.celrep.2020.02.063","volume":"30","author":"Yang M.","year":"2020","unstructured":"Yang M.; Lin X.; Segers F.; Suganthan R.; Hildrestrand G.A.; Rinholm J.E.; Aas P.A.; Sousa M.M.L.; Holm S.; Bolstad N.; Warren D.; Berge R.K.; Johansen R.F.; Yndestad A.; Kristiansen E.; Klungland A.; Luna L.; Eide L.; Halvorsen B.; Aukrust P.; Bj\u00f8r\u00e5s M.; OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation. Cell Rep 2020,30(12),4165-4178","journal-title":"Cell Rep"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3389\/fonc.2020.01025","volume":"10","author":"Zhang B.","year":"2020","unstructured":"Zhang B.; Zhou B.; Xiao M.; Li H.; Guo L.; Wang M.; Yu S.; Ye Q.; KDM5C represses FASN-Mediated lipid metabolism to exert tumor suppressor activity in intrahepatic cholangiocarcinoma. Front Oncol 2020,10,1025","journal-title":"Front Oncol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1128\/MCB.01404-14","volume":"35","author":"Nagaoka K.","year":"2015","unstructured":"Nagaoka K.; Hino S.; Sakamoto A.; Anan K.; Takase R.; Umehara T.; Yokoyama S.; Sasaki Y.; Nakao M.; Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells. Mol Cell Biol 2015,35(7),1068-1080","journal-title":"Mol Cell Biol"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147692","volume":"6","author":"Cao Y.","year":"2021","unstructured":"Cao Y.; Tang L.; Du K.; Paraiso K.; Sun Q.; Liu Z.; Ye X.; Fang Y.; Yuan F.; Chen H.; Chen Y.; Wang X.; Yu C.; Blitz I.L.; Wang P.H.; Huang L.; Cheng H.; Lu X.; Cho K.W.Y.; Seldin M.; Fang Z.; Yang Q.; Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1. JCI Insight 2021,6(17)","journal-title":"JCI Insight"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.2337\/db21-1131","volume":"71","author":"Ramms B.","year":"2022","unstructured":"Ramms B.; Pollow D.P.; Zhu H.; Nora C.; Harrington A.R.; Omar I.; Gordts P.L.S.M.; Wortham M.; Sander M.; Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity. Diabetes 2022,71(12),2513-2529","journal-title":"Diabetes"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/gtc.12627","volume":"23","author":"Kang C.","year":"2018","unstructured":"Kang C.; Saso K.; Ota K.; Kawazu M.; Ueda T.; Okada H.; JMJD2B\/KDM4B inactivation in adipose tissues accelerates obesity and systemic metabolic abnormalities. Genes Cells 2018,23(9),767-777","journal-title":"Genes Cells"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"13734","DOI":"10.1038\/s41598-018-31953-x","volume":"8","author":"Kim J.H.","year":"2018","unstructured":"Kim J.H.; Jung D.Y.; Nagappan A.; Jung M.H.; Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPAR\u03b32. Sci Rep 2018,8(1),13734","journal-title":"Sci Rep"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.3390\/ijms21218313","volume":"21","author":"Kim J.H.","year":"2020","unstructured":"Kim J.H.; Jung D.Y.; Kim H.R.; Jung M.H.; Histone H3K9 demethylase JMJD2B plays a role in LXR\u03b1-dependent lipogenesis. Int J Mol Sci 2020,21(21),8313","journal-title":"Int J Mol Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.21037\/atm-21-4222","volume":"10","author":"Chu Q.","year":"2022","unstructured":"Chu Q.; Gu X.; Zheng Q.; Zhu H.; Regulatory mechanism of HIF-1\u03b1 and its role in liver diseases: A narrative review. Ann Transl Med 2022,10(2),109","journal-title":"Ann Transl Med"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbagrm.2017.08.002","volume":"1860","author":"Fan Z.","year":"2017","unstructured":"Fan Z.; Li Z.; Yang Y.; Liu S.; Guo J.; Xu Y.; HIF-1\u03b1 coordinates epigenetic activation of SIAH1 in hepatocytes in response to nutritional stress. Biochim Biophys Acta Gene Regul Mech 2017,1860(10),1037-1046","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41467-018-04361-y","volume":"9","author":"Bricambert J.","year":"2018","unstructured":"Bricambert J.; Alves-Guerra M.C.; Esteves P.; Prip-Buus C.; Bertrand-Michel J.; Guillou H.; Chang C.J.; Vander Wal M.N.; Canonne-Hergaux F.; Mathurin P.; Raverdy V.; Pattou F.; Girard J.; Postic C.; Dentin R.; The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun 2018,9(1),2092","journal-title":"Nat Commun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.molcel.2019.05.019","volume":"75","author":"Lane E.A.","year":"2019","unstructured":"Lane E.A.; Choi D.W.; Garcia-Haro L.; Levine Z.G.; Tedoldi M.; Walker S.; Danial N.N.; HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP. Mol Cell 2019,75(2),357-371.e7","journal-title":"Mol Cell"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41467-020-14617-1","volume":"11","author":"Viscarra J.A.","year":"2020","unstructured":"Viscarra J.A.; Wang Y.; Nguyen H.P.; Choi Y.G.; Sul H.S.; Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. Nat Commun 2020,11(1),796","journal-title":"Nat Commun"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1172\/JCI128073","volume":"130","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Lin H.; Jiang L.; Shang Q.; Yin L.; Lin J.D.; Wu W.S.; Rui L.; Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes. J Clin Invest 2020,130(6),2992-3004","journal-title":"J Clin Invest"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1172\/JCI97736","volume":"128","author":"Seok S.","year":"2018","unstructured":"Seok S.; Kim Y.C.; Byun S.; Choi S.; Xiao Z.; Iwamori N.; Zhang Y.; Wang C.; Ma J.; Ge K.; Kemper B.; Kemper J.K.; Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid \u03b2-oxidation. J Clin Invest 2018,128(7),3144-3159","journal-title":"J Clin Invest"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","volume":"11","author":"Byun S.","year":"2020","unstructured":"Byun S.; Seok S.; Kim Y.C.; Zhang Y.; Yau P.; Iwamori N.; Xu H.E.; Ma J.; Kemper B.; Kemper J.K.; Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun 2020,11(1),807","journal-title":"Nat Commun"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10020-021-00428-7","volume":"28","author":"Zhao F.","year":"2022","unstructured":"Zhao F.; Ke J.; Pan W.; Pan H.; Shen M.; Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1. Mol Med 2022,28(1),12","journal-title":"Mol Med"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac127","volume":"163","author":"Roy S.","year":"2022","unstructured":"Roy S.; Abudu A.; Salinas I.; Sinha N.; Cline-Fedewa H.; Yaw A.M.; Qi W.; Lydic T.A.; Takahashi D.L.; Hennebold J.D.; Hoffmann H.M.; Wang J.; Sen A.; Androgen-mediated perturbation of the hepatic circadian system through epigenetic modulation promotes NAFLD in PCOS mice. Endocrinology 2022,163(10)","journal-title":"Endocrinology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.3390\/ijms222011085","volume":"22","author":"Kim J.H.","year":"2021","unstructured":"Kim J.H.; Nagappan A.; Jung D.; Suh N.; Jung M.; Histone demethylase KDM7A contributes to the development of hepatic steatosis by targeting diacylglycerol acyltransferase 2. Int J Mol Sci 2021,22(20),11085","journal-title":"Int J Mol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/cells11020181","volume":"11","author":"Li F.","year":"2022","unstructured":"Li F.; Wang S.; Cui X.; Jing J.; Yu L.; Xue B.; Shi H.; Adipocyte Utx deficiency promotes high-fat diet-induced metabolic dysfunction in mice. Cells 2022,11(2),181","journal-title":"Cells"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1038\/s41467-022-31476-0","volume":"13","author":"Chen H.","year":"2022","unstructured":"Chen H.; Liu C.; Wang Q.; Xiong M.; Zeng X.; Yang D.; Xie Y.; Su H.; Zhang Y.; Huang Y.; Chen Y.; Yue J.; Liu C.; Wang S.; Huang K.; Zheng L.; Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver. Nat Commun 2022,13(1),3835","journal-title":"Nat Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41418-020-00714-7","volume":"28","author":"Chen L.","year":"2021","unstructured":"Chen L.; Zhang J.; Zou Y.; Wang F.; Li J.; Sun F.; Luo X.; Zhang M.; Guo Y.; Yu Q.; Yang P.; Zhou Q.; Chen Z.; Zhang H.; Gong Q.; Zhao J.; Eizirik D.L.; Zhou Z.; Xiong F.; Zhang S.; Wang C.Y.; Kdm2a deficiency in macrophages enhances thermogenesis to protect mice against HFD-induced obesity by enhancing H3K36me2 at the Pparg locus. Cell Death Differ 2021,28(6),1880-1899","journal-title":"Cell Death Differ"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.590369","volume":"11","author":"Asif S.","year":"2020","unstructured":"Asif S.; Morrow N.M.; Mulvihill E.E.; Kim K.H.; Understanding dietary intervention-mediated epigenetic modifications in metabolic diseases. Front Genet 2020,11","journal-title":"Front Genet"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cells11030409","volume":"11","author":"Pascale R.M.","year":"2022","unstructured":"Pascale R.M.; Simile M.M.; Calvisi D.F.; Feo C.F.; Feo F.; S-Adenosylmethionine: From the discovery of its inhibition of tumorigenesis to its use as a therapeutic agent. Cells 2022,11(3),409","journal-title":"Cells"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"G634","DOI":"10.1152\/ajpgi.00249.2009","volume":"298","author":"Wang Z.","year":"2010","unstructured":"Wang Z.; Yao T.; Pini M.; Zhou Z.; Fantuzzi G.; Song Z.; Betaine improved adipose tissue function in mice fed a high-fat diet: A mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2010,298(5),G634-G642","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbalip.2015.10.002","volume":"1861","author":"Cai D.","year":"2016","unstructured":"Cai D.; Wang J.; Jia Y.; Liu H.; Yuan M.; Dong H.; Zhao R.; Gestational dietary betaine supplementation suppresses hepatic expression of lipogenic genes in neonatal piglets through epigenetic and glucocorticoid receptor-dependent mechanisms. Biochim Biophys Acta Mol Cell Biol Lipids 2016,1861(1),41-50","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3945\/ajcn.111.020156","volume":"95","author":"Guerrerio A.L.","year":"2012","unstructured":"Guerrerio A.L.; Colvin R.M.; Schwartz A.K.; Molleston J.P.; Murray K.F.; Diehl A.; Mohan P.; Schwimmer J.B.; Lavine J.E.; Torbenson M.S.; Scheimann A.O.; Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr 2012,95(4),892-900","journal-title":"Am J Clin Nutr"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.7150\/thno.69054","volume":"12","author":"Wang S.","year":"2022","unstructured":"Wang S.; Lin Y.; Gao L.; Yang Z.; Lin J.; Ren S.; Li F.; Chen J.; Wang Z.; Dong Z.; Sun P.; Wu B.; PPAR-\u03b3 integrates obesity and adipocyte clock through epigenetic regulation of Bmal1. Theranostics 2022,12(4),1589-1606","journal-title":"Theranostics"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","volume":"508","author":"Kraus D.","year":"2014","unstructured":"Kraus D.; Yang Q.; Kong D.; Banks A.S.; Zhang L.; Rodgers J.T.; Pirinen E.; Pulinilkunnil T.C.; Gong F.; Wang Y.; Cen Y.; Sauve A.A.; Asara J.M.; Peroni O.D.; Monia B.P.; Bhanot S.; Alhonen L.; Puigserver P.; Kahn B.B.; Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 2014,508(7495),258-262","journal-title":"Nature"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","volume":"51","author":"Pogribny I.P.","year":"2009","unstructured":"Pogribny I.P.; Tryndyak V.P.; Bagnyukova T.V.; Melnyk S.; Montgomery B.; Ross S.A.; Latendresse J.R.; Rusyn I.; Beland F.A.; Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 2009,51(1),176-186","journal-title":"J Hepatol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/hep.22159","volume":"47","author":"Mart\u00ednez-Chantar M.L.","year":"2008","unstructured":"Mart\u00ednez-Chantar M.L.; V\u00e1zquez-Chantada M.; Ariz U.; Mart\u00ednez N.; Varela M.; Luka Z.; Capdevila A.; Rodr\u00edguez J.; Aransay A.M.; Matthiesen R.; Yang H.; Calvisi D.F.; Esteller M.; Fraga M.; Lu S.C.; Wagner C.; Mato J.M.; Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008,47(4),1191-1199","journal-title":"Hepatology"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2015.02.021","volume":"284","author":"Strakovsky R.S.","year":"2015","unstructured":"Strakovsky R.S.; Wang H.; Engeseth N.J.; Flaws J.A.; Helferich W.G.; Pan Y.X.; Lezmi S.; Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis. Toxicol Appl Pharmacol 2015,284(2),101-112","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"fj201700717RR.","DOI":"10.1096\/fj.201700717RR","volume":"2018","author":"Ramon-Krauel M","year":"2018","unstructured":"Ramon-Krauel M; Pentinat T; Bloks VW; Cebri\u00e0 J; Ribo S; P\u00e9rez-Wienese R; Epigenetic programming at the Mogat1 locus may link neonatal overnutrition with long-term hepatic steatosis and insulin resistance. Faseb j 2018,2018,fj201700717RR.","journal-title":"Faseb j"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jhep.2011.10.018","volume":"56","author":"Li J.","year":"2012","unstructured":"Li J.; Huang J.; Li J.S.; Chen H.; Huang K.; Zheng L.; Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. J Hepatol 2012,56(4),900-907","journal-title":"J Hepatol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"G558","DOI":"10.1152\/ajpgi.00032.2011","volume":"302","author":"Zhang X.","year":"2012","unstructured":"Zhang X.; Zhou D.; Strakovsky R.; Zhang Y.; Pan Y.X.; Hepatic cellular senescence pathway genes are induced through histone modifications in a diet-induced obese rat model. Am J Physiol Gastrointest Liver Physiol 2012,302(5),G558-G564","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12263-018-0595-5","volume":"13","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Xu G.B.; Zhou D.; Pan Y.X.; High-fat diet modifies expression of hepatic cellular senescence gene p16(INK4a) through chromatin modifications in adult male rats. Genes Nutr 2018,13(1),6","journal-title":"Genes Nutr"},{"key":"ref=86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066816","volume":"8","author":"Attig L.","year":"2013","unstructured":"Attig L.; Vig\u00e9 A.; Gabory A.; Karimi M.; Beauger A.; Gross M.S.; Athias A.; Gallou-Kabani C.; Gambert P.; Ekstrom T.J.; Jais J.P.; Junien C.; Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures. PLoS One 2013,8(6)","journal-title":"PLoS One"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.nut.2015.01.005","volume":"31","author":"Suzuki T.","year":"2015","unstructured":"Suzuki T.; Muramatsu T.; Morioka K.; Goda T.; Mochizuki K.; ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model. Nutrition 2015,31(6),877-883","journal-title":"Nutrition"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbrc.2016.12.129","volume":"483","author":"Du X.","year":"2017","unstructured":"Du X.; Cai C.; Yao J.; Zhou Y.; Yu H.; Shen W.; Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. Biochem Biophys Res Commun 2017,483(1),409-417","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tig.2020.03.003","volume":"36","author":"Bayoumi A.","year":"2020","unstructured":"Bayoumi A.; Gr\u00f8nb\u00e6k H.; George J.; Eslam M.; The epigenetic drug discovery landscape for metabolic-associated fatty liver disease. Trends Genet 2020,36(6),429-441","journal-title":"Trends Genet"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/md18010069","volume":"18","author":"Wang Q.","year":"2020","unstructured":"Wang Q.; Jiang Y.; Luo X.; Wang C.; Wang N.; He H.; Zhang T.; Chen L.; Chitooligosaccharides modulate glucose-lipid metabolism by suppressing smyd3 pathways and regulating gut microflora. Mar Drugs 2020,18(1),69","journal-title":"Mar Drugs"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"552","DOI":"10.21037\/atm-22-1753","volume":"10","author":"Dai L.","year":"2022","unstructured":"Dai L.; Lu S.; Shen T.; Li Y.; Chen J.; Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis. Ann Transl Med 2022,10(10),552","journal-title":"Ann Transl Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ymthe.2016.10.004","volume":"25","author":"Zeybel M.","year":"2017","unstructured":"Zeybel M.; Luli S.; Sabater L.; Hardy T.; Oakley F.; Leslie J.; Page A.; Moran Salvador E.; Sharkey V.; Tsukamoto H.; Chu D.C.K.; Singh U.S.; Ponzoni M.; Perri P.; Di Paolo D.; Mendivil E.J.; Mann J.; Mann D.A.; A proof-of-concept for epigenetic therapy of tissue fibrosis: Inhibition of liver fibrosis progression by 3-deazaneplanocin A. Mol Ther 2017,25(1),218-231","journal-title":"Mol Ther"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389203724666230526155643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217390\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389203724666230526155643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T09:18:59Z","timestamp":1694078339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217390\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203724666230526155643","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}